Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy
an observational study
Keywords:
Prostate cancer, Erectile dysfunction, Self-injection therapy, Radical prostatectomyAbstract
CONTEXT: Despite the recent improvements in performing radical retropubic prostatectomy that have led to a considerable decrease in the complication rate, erectile dysfunction still represents a major problem. Moreover, less invasive treatment options that are emerging for erectile dysfunction have not shown satisfactory results in managing these patients. OBJECTIVE: To study the efficacy and side effects of self-injection therapy in the treatment of men who had become impotent after undergoing radical prostatectomy due to prostate cancer, over a study period of 96 months. DESIGN: Observational study. SETTING: University Referral Center. PARTICIPANTS: 168 patients with erectile dysfunction, aged 43 to 78 years old, who underwent radical retropubic prostatectomy due to localized prostate cancer. PROCEDURES: The patients were treated with self-injection therapy using papaverine, phentolamine and prostaglandin E1, at home. RESULTS: This study showed an acceptable 94.6% success rate, with no life-threatening complications. In addition to this, our series presented a 13.1% cure rate with this therapy. CONCLUSION: Self-injection therapy with papaverine, phentolamine and prostaglandin E1 is effective and safe in the treatment of erectile dysfunction after radical prostatectomy.
Downloads
References
Srougi M. Câncer da próstata. In: Srougi M, Simon SD, editores. Câncer Urológico. 2nd ed. São Paulo: Marprint; 1996:281-359.
Srougi M. Prostatectomia radical com preservação da potência sexual. In: Srougi M, Simon SD, editores. Câncer Urológico. 2nd ed. São Paulo: Marprint; 1996:361-76.
Geary ES, Dedinger TE, Freiha FS, Stamey TA. Nerve-sparing radical prostatectomy: a different view. J Urol 1995;154:145-9.
Claro JA. Disfunção sexual masculina. In: Ramos OL, Rothschild HA, editors. Atualização terapêutica. 19th ed. São Paulo: Artes Médicas; 1999:1196-8.
Claro JA, Nardozza A Jr, Lopes J, et al. Sildenafil no tratamento da disfunção erétil pós-prostatectomia radical. J Bras Urol 1999;25(4):504-7.
Claro JA, Oliveira F, Nardozza A Jr, Aboim JE, Romualdo MC, Srougi M. Alprostadil transuretral no tratamento da disfunção erétil. J Bras Urol 1999;25:73-8.
Claro JA, Nardozza A Jr, Srougi M, et al. Auto-injeção intracavernosa na impotência e qualidade de vida. Rev Bras Med 1997;54:825-33.
Claro JA, Nardozza A Jr, Srougi M. Injeção intracavernosa da associação de prostaglandina E1, fentolamina e papaverina no tratamento da disfunção sexual. J Bras Urol 1998;24:153-6.
Claro JA, Andrade E, Fregonesi A, et al. Auto-injeção de drogas vasoativas no tratamento da impotência. Rev Bras Med 1994;51:1344-7.
Ohari M, Wheeler TM, Dunn IK, et al. Pathologic features and prognosis of prostate cancer detectable with current diag- nosis tests. J Urol 1994;151(suppl):451A(894)abstr.
Walsh PC, Dinker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128:492-7.
Catalona WJ, Basler IW. Return of erections and urinary conti- nence following nerve sparing radical retropubic prostatectomy. J Urol 1993;150:905-7.
Claro JA. Disfunção sexual masculina. In: Schor N, Srougi M, editors. Nefrologia, urologia clínica. 1st ed. São Paulo: Sarvier; 1998:254-62.
Spahn M, Manning M, Juenemamm KP. Intracavernosal therapy. In: Carson CC III, Kirby RS, Goldstein I, editors. Text- book of erectile dysfunction. 1st ed. Oxford: Isis Medical Me- dia; 1999:345-53.
Montorsi F, Guazzoni G, Barbieri L, et al. Recovery of sponta- neous erectile function after nerve sparing radical prostatectomy with and without early intracavernous injections of prostaglan- din E1: results of a prospective randomized trial. J Urol 1996;155(suppl):468A.
